The Aging Crisis:
A Global Health Challenge
While life expectancy has significantly increased over the past century, healthspan (the period of life spent in good health) has not kept pace. On average, people spend their final decades battling multiple chronic conditions such as cardiovascular diseases, diabetes, neurodegenerative disorders, and cancers. This mismatch strains healthcare systems and reduces quality of life globally. Traditional medicine is focused on treating one disease at a time without considering how multiple chronic health conditions might be connected.
Our Solution:
Multi-Target Anti-Aging Therapeutics
Proactively treating or slowing aging (preventative care) is a multi-disease approach, targeting biology rather than a single illness, and the key to improving healthspan. While conventional drugs target a single disease, Pan-Biome aims to shift the paradigm toward preventive care, targeting multiple biological mechanisms simultaneously to delay or prevent the onset of multiple chronic conditions simultaneously. In preclinical studies Pan-Biome’s lead compound modulates key biological pathways associated with aging and age-related diseases, including chronic inflammation, metabolic dysregulation, activation of stress sensors (AMPK and Nrf2), and gut microbiome modulation. Pan-Biome compounds significantly extended lifespan in C elegans (a premier model for lifespan studies).
Who We’re Working With
Contact
Investor Inquiries:
Gordon Eberwein
geberwein@derm-biome.com
https://derm-biomepharmaceuticals.com/
https://pan-biomepharmaceuticals.com/